The longer-term effects of Roux-en-Y gastric bypass surgery on sodium excretion

Obesity Surgery

Volumn 23, Issue 3, 2013, Pages 358-364

  Celik, Funda ^a   Ahdi, Mohamed ^a   Meesters, Eelco W ^a   Van De Laar, Arnold ^a   Brandjes, Dees P M ^a,b   Gerdes, Victor E A ^a,b  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Microalbuminuria; Obesity; Salt intake; Urinary sodium excretion

Indexed keywords

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BARIATRIC SURGERY; BLOOD PRESSURE MEASUREMENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; SODIUM EXCRETION; STOMACH BYPASS; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; URINALYSIS; WEIGHT REDUCTION;

ADULT; ALBUMINURIA; BLOOD PRESSURE; BODY MASS INDEX; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; HUMANS; HYPERTENSION; LAPAROSCOPY; MALE; MIDDLE AGED; NETHERLANDS; OBESITY, MORBID; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RISK FACTORS; SODIUM; TIME FACTORS; WEIGHT LOSS;

EID: 84878830861     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-012-0764-3     Document Type: Article

References (41)

1. Garrett JR, McNolty LA. Bariatric surgery and the social character of the obesity epidemic. Am J Bioeth. 2010;10:20-2.
2. Chen J, Gu D, Huang J, et al. Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study. Lancet. 2009;373:829-35.
3. Laville M. Renal consequences of obesity. Nephrol Ther. 2011;7:80-5.
4. Hall JE, Henegar JR, Dwyer TM, et al. Is obesity a major cause of chronic kidney disease? Adv Ren Replace Ther. 2004;11:41-54.
5. Serra A, Romero R, Lopez D, et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int. 2008;73:947-55.
6. Wu Y, Liu Z, Xiang Z, et al. Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology. 2006;147:44-50.
7. Chagnac A, Weinstein T, Korzets A, et al. Glomerular hemodynamics in severe obesity. Am J Physiol Ren Physiol. 2000;278:F817-22.
8. Chagnac A, Herman M, Zingerman B, et al. Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption. Nephrol Dial Transplant. 2008;23:3946-52.
9. Cubeddu LX, Hoffmann IS, Aponte LM, et al. Role of salt sensitivity, blood pressure, and hyperinsulinemia in determining high upper normal levels of urinary albumin excretion in a healthy adult population. Am J Hypertens. 2003;16:343-9.
10. Ritz E, Koleganova N, Piecha G. Is there an obesity-metabolic syndrome related glomerulopathy? Curr Opin Nephrol Hypertens. 2011;20:44-9.
11. Konta T, Hao Z, Abiko H, et al. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study. Kidney Int. 2006;70:751-6.
12. Verhave JC, Hillege HL, Burgerhof JG, et al. Sodium intake affects urinary albumin excretion especially in overweight subjects. J Int Med. 2004;256:324-30.
13. Fujita T, Ando K. Role of electrolytes in the development and maintenance of hypertension. Nihon Naibunpi Gakkai Zasshi. 1994;70:423-30.
14. Andersson OK, Fagerberg B, Hedner T. Importance of dietary salt in the hemodynamic adjustment to weight reduction in obese hypertensive men. Hypertension. 1984;6:814-9.
15. Kumanyika SK, Cook NR, Cutler JA, et al. Sodium reduction for hypertension prevention in overweight adults: further results from the Trials of Hypertension Prevention Phase II. J Hum Hypertens. 2005;19:33-45.
16. Fagerberg B, Andersson OK, Isaksson B, et al. Blood pressure control during weight reduction in obese hypertensive men: separate effects of sodium and energy restriction. Br Med J (Clin Res Ed). 1984;288:11-4.
17. Rissanen A, Pietinen P, Siljamaki-Ojansuu U, et al. Treatment of hypertension in obese patients: efficacy and feasibility of weight and salt reduction programs. Acta Med Scand. 1985;218:149-56.
18. van de Borne P, Watrin I, Bouquegneau M, et al. Ambulatory blood pressure and neuroendocrine control after diet-assisted gastric restrictive surgery. J Hypertens. 2000;18:301-6.
19. Kumar R, Lieske JC, Collazo-Clavell ML, et al. Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery. Surgery. 2011;149:654-61.
20. Davis BR, Oberman A, Blaufox MD, et al. Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. TAIM Research Group. Trial of Antihypertensive Interventions and Management. Am J Hypertens. 1994;7:926-32.
21. Hall JE. The kidney, hypertension, and obesity. Hypertension. 2003;41:625-33.
22. Brown IJ, Tzoulaki I, Candeias V, et al. Salt intakes around the world: implications for public health. Int J Epidemiol. 2009;38:791-813.
23. Michels WM, Grootendorst DC, Verduijn M, et al. Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol. 2010;5:1003-9.
24. Pekkarinen T, Takala I, Mustajoki P. Weight loss with very-low-calorie diet and cardiovascular risk factors in moderately obese women: one-year follow-up study including ambulatory blood pressure monitoring. Int J Obes Relat Metab Disord. 1998;22:661-6.
25. Caroline van den Hooven, Heidi Fransen, Eugene Jansen, Marga Ocke: 24-uurs urine-excretie van natrium, 2007 (Dutch). Retrieved from: www.rivm.nl.
26. Powell CR, Stoller ML, Schwartz BF, et al. Impact of body weight on urinary electrolytes in urinary stone formers. Urology. 2000;55:825-30.
27. Taylor EN, Curhan GC. Body size and 24-hour urine composition. Am J Kidney Dis. 2006;48:905-15.
28. Venezia A, Barba G, Russo O, et al. Dietary sodium intake in a sample of adult male population in southern Italy: results of the Olivetti Heart Study. Eur J Clin Nutr. 2010;64:518-24.
29. Zhang J, Temme EH, Sasaki S, et al. Under- and overreporting of energy intake using urinary cations as biomarkers: relation to body mass index. Am J Epidemiol. 2000;152:453-62.
30. Heber D, Greenway FL, Kaplan LM, et al. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95:4823-43.
31. Burge JC, Schaumburg JZ, Choban PS, et al. Changes in patients' taste acuity after Roux-en-Y gastric bypass for clinically severe obesity. J Am Diet Assoc. 1995;95:666-70.
32. Aoi W, Ueda Y, Tanigawa M. Effect of weight loss on the reduction of blood pressure in obesity hypertension - hyperinsulinemia and renal sodium retention. Nihon Jinzo Gakkai Shi. 1992;34:1177-82.
33. Eliahou HE, Erdberg A, Blau A. Energy restriction or salt restriction in the treatment of overweight hypertension. Which one? A point of view. Clin Exp Hypertens A. 1990;12:795-802.
34. Navarro-Diaz M, Serra A, Romero R, et al. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J Am Soc Nephrol. 2006;17:S213-7.
35. Ohashi H, Oda H, Ohno M, et al. Weight reduction improves high blood pressure and microalbuminuria in hypertensive patients with obesity. Nihon Jinzo Gakkai Shi. 2001;43:333-9.
36. Serpa NA, Bianco Rossi FM, Dal Moro AR, et al. Effect of weight loss after Roux-en-Y gastric bypass, on renal function and blood pressure in morbidly obese patients. J Nephrol. 2009;22:637-46.
37. Afshinnia F, Wilt TJ, Duval S, et al. Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. Nephrol Dial Transplant. 2010;25:1173-83.
38. Agrawal V, Krause KR, Chengelis DL, et al. Relation between degree of weight loss after bariatric surgery and reduction in albuminuria and C-reactive protein. Surg Obes Relat Dis. 2009;5:20-6.
39. Chagnac A, Weinstein T, Herman M, et al. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol. 2003;14:1480-6.
40. Serra A, Granada ML, Romero R, et al. The effect of bariatric surgery on adipocytokines, renal parameters and other cardiovascular risk factors in severe and very severe obesity: 1-year follow-up. Clin Nutr. 2006;25:400-8.
41. Uzu T, Sakaguchi M, Yokomaku Y, et al. Effects of high sodium intake and diuretics on the circadian rhythm of blood pressure in type 2 diabetic patients treated with an angiotensin II receptor blocker. Clin Exp Nephrol. 2009;13:300-6.